Is Cigna Group (CI) Undervalued After Its New Dividend Declaration?
The Cigna Group (CI) announced new income terms, with its board approving a cash dividend of US$1.56 per share, payable on 17 December 2026 to holders of record on 3 December.
The dividend decision comes as Cigna Group’s share price sits at US$298.23, after a 10.24% one-month share price return and a 6.85% share price gain year to date. The 1-year total shareholder return of 24.79% points to momentum that has been building rather than fading.
See how Cigna Group’s dividend move compares with other potential income ideas by reviewing our hand picked 5 dividend fortresses.
Cigna Group has already delivered a strong 1 year run, yet the new dividend and recent move keep the story in motion. How much of the upside is still on the table, and how much is already in the rear-view mirror?
Most Popular Narrative: 53% Undervalued
Cigna Group’s last close at $298.23 sits well below a narrative fair value of $636.28. As a result, the dividend story now intersects with a much larger valuation gap that some investors are watching closely.
Cigna offers a 55.3% raw discount because the market is not valuing growing earnings in isolation. It is pricing political hostility toward PBMs, restrictions on Express Scripts, uncertainty around automated claims review, declining customer counts, uneven cash conversion, and the possibility that today’s most profitable practices may not remain tomorrow’s permissible ones.
See why 4 investors see Cigna Group as 53% undervalued.
Result: Fair Value of $636.28 (UNDERVALUED)
Still, the long FTC monitoring of Express Scripts and the ongoing PxDx litigation could both undermine confidence in Cigna Group’s valuation story.
Find out about the key risks to this Cigna Group narrative.
Next Steps
Plenty in this Cigna Group story pulls in different directions, so act while the facts are fresh and decide where you stand using the full 5 key rewards and 1 important warning sign
Looking for more investment ideas beyond Cigna Group?
If Cigna Group has your attention right now, do not stop there. Use the tools available and give yourself more options before you commit.
- Target resilient cash generators by scanning a list of solid balance sheet and fundamentals (24 results) that filters for healthier finances and sturdier fundamentals.
- Spot potential mispriced opportunities early by reviewing a curated 19 high quality undiscovered gems built around strong underlying business quality.
- Strengthen your income shortlist by comparing Cigna Group’s payout with a focused 29 resilient stocks with low risk scores offering steadier profiles and lower overall risk.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com